The predicted global cancer burden is expected to grow to 27.5 million new cancer cases by 2040 due to the rapid growth and aging of the population worldwide. Some of the most common cancer types, such as breast cancer, cervical cancer, oral cancer and colorectal cancer are largely curable if they are detected early and treated appropriately1. With a disease so prevalent, clinicians require accuracy, precision, and speed while planning for radiation therapy treatment. Giving clinicians the opportunity to see more during radiation therapy planning, Canon Medical Systems. is introducing the Aquilion Exceed LBTM CT scanner (pending 510(k) clearance) during this year’s virtual American Society for Radiation Oncology (ASTRO) Annual Meeting.
Canon Medical CEO, Toshio Takiguchi, said, “At Canon Medical, we deliver solutions that meet healthcare providers’ needs but also push the boundaries of traditional CT simulation. Accurate simulation across even the most challenging radiation therapy treatment plans is imperative during the planning phase of the patient care journey. With the Aquilion Exceed LB, we brought deep learning reconstruction technology to the radiation oncology market. This will give the radiation oncology team the confidence and precision they need for accurate therapy planning for their patients and will leave patients with a positive experience when undergoing a CT scan.”
The Aquilion Exceed LB can help radiation oncologists with fast and efficient radiation oncology workflows without compromising on patient position, image quality, or reproducibility.
- Accuracy in even the most complex simulations through industry-leading capabilities, like the largest bore size (90 cm), edge-to-edge extended Field-of-View (90 cm) reconstruction, and widest detector coverage (4 cm).
- Better contouring using Artificial Intelligence (AI) with sharp, clear and distinct images from Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology.
- Expanded capabilities – because of the Aquilion Exceed LB’s suite of premium CT capabilities to further increase clinical utility, it integrates seamlessly with a range of respiratory gating devices and can perform both phase and amplitude sorting.
Learn more about Canon Medical’s new Aquilion Exceed LB CT system by visiting our virtual booth during ASTRO, October 23 – 29, 2020.
1) International Agency for Research on Cancer (IARC) February 2020: https://www.iarc.fr/wp-content/uploads/2020/02/pr279_E.pdf
Aquilion Exceed LB and Made for life are trademarks of Canon Medical Systems.